You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Recommended technology to relieve oral mucositis not yet available for children or young people in England or Wales
  1. Melody Redman1,2,
  2. Katherine Harris3,
  3. Jessica Elizabeth Morgan4,
  4. Robert Phillips4
  1. 1 Department of Oncology of Metabolism, University of Sheffield, Sheffield, UK
  2. 2 Sheffield Children’s Hospital, Sheffield, UK
  3. 3 Hull York Medical School, York, UK
  4. 4 Centre for Reviews and Dissemination, University of York, York, UK
  1. Correspondence to Dr Melody Redman, Department of Oncology of Metabolism, University of Sheffield, Sheffield S10 2TN, UK; meloredman{at}gmail.com

http://dx.doi.org/10.1136/archdischild-2019-317542

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We thank Professor Dimitri of the National Institute for Health Research Children and Young People Medical Technology Co-operative (NIHR CYP MedTech) for sharing his insight into the future role of child health technology across the National Health Service.1 We agree that there are clear roles for developing new technologies to address some of the unmet health needs of CYP. We note that there is difficulty incorporating existing technologies into UK child health. Our research groups are interested in supportive care in cancer and are exploring the role of low-level laser therapy (LLLT). This handheld tool is applied to the oral mucosa …

    View Full Text

    Footnotes

    • Contributors All authors contributed to the background information and letter.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests MR, KH and RP are undertaking a systematic review on the use of LLLT to prevent or treat oral mucositis in children with cancer (PROSPERO registration: CRD42018099772).

    • Patient consent for publication Parental consent obtained.

    • Provenance and peer review Not commissioned; internally peer reviewed.